ReviewTherapeutic advances in neurological disorders2017

OnabotulinumtoxinA in the treatment of patients with chronic migraine: clinical evidence and experience.

Chia-Chun Chiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.